However, reverse phase protein array (RPPA)-based protein profiling of NEK1 and YAP1 in PRAD patients from TCGA datasets revealed upregulation of YAP1 level (Figure 5D), but no change in NEK1 protein level (Figure 5C). Here, NEK1 is linked to prostate adenocarcinoma.